OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
30
Results
Show all
Save search
Copy query
Show results for
Unknown
(28)
Proteomics
(2)
Repository
PAXDB
(2)
Publication Date
2018
(1)
2016
(1)
UNIPROT ID/AC
8030.ENSSSAP00000000285
(2)
8030.ENSSSAP00000000573
(2)
8030.ENSSSAP00000000871
(2)
8030.ENSSSAP00000001022
(2)
8030.ENSSSAP00000001240
(2)
8030.ENSSSAP00000001597
(2)
8030.ENSSSAP00000002059
(2)
8030.ENSSSAP00000002148
(2)
8030.ENSSSAP00000002643
(2)
8030.ENSSSAP00000002671
(2)
8030.ENSSSAP00000002680
(2)
8030.ENSSSAP00000002684
(2)
8030.ENSSSAP00000002690
(2)
8030.ENSSSAP00000002813
(2)
8030.ENSSSAP00000003421
(2)
8030.ENSSSAP00000003619
(2)
8030.ENSSSAP00000004639
(2)
8030.ENSSSAP00000004862
(2)
8030.ENSSSAP00000005034
(2)
8030.ENSSSAP00000005299
(2)
8030.ENSSSAP00000005382
(2)
8030.ENSSSAP00000005521
(2)
8030.ENSSSAP00000005622
(2)
8030.ENSSSAP00000006110
(2)
8030.ENSSSAP00000006568
(2)
8030.ENSSSAP00000006671
(2)
8030.ENSSSAP00000006691
(2)
8030.ENSSSAP00000006723
(2)
8030.ENSSSAP00000006772
(2)
8030.ENSSSAP00000006853
(2)
Release Date
2022
(4)
2015
(4)
2016
(3)
2024
(2)
2023
(2)
2021
(2)
2014
(2)
2013
(2)
2012
(2)
2009
(2)
2018
(1)
2011
(1)
2010
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Phase I trial of anti-CD22 recombinant immunotoxin moxetumomab pasudotox (CAT-8015 or HA22) in patients with hairy cell leukemia.
Not available
S-EPMC3383181
|
biostudies-literature
Cite
Ssalar - Liver, iBAQ (Nuez-ortinetal,plosone2016)
abundance based on iBAQ, Interaction consistency score: 4.8, Coverage: 7
ORGANISM(S):
8030
2016-00-00
|
587673189
|
PAXDB
Cite
Ssalar - Liver, iBAQ (Nuez-ortinetal,bmcgenomics2018)
abundance based on iBAQ, Interaction consistency score: 4.4, Coverage: 8
ORGANISM(S):
8030
2018-00-00
|
557577734
|
PAXDB
Cite
Preliminary findings from the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: a Randomized Controlled Trial.
Not available
S-EPMC11118649
|
biostudies-literature
Cite
Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial.
Not available
S-EPMC11478574
|
biostudies-literature
Cite
Discrepancy between disability and reported well-being after traumatic brain injury.
Not available
S-EPMC9279746
|
biostudies-literature
Cite
Serum metabolome associated with severity of acute traumatic brain injury.
Not available
S-EPMC9090763
|
biostudies-literature
Cite
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy.
Not available
S-EPMC10408259
|
biostudies-literature
Cite
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Not available
S-EPMC2806600
|
biostudies-literature
Cite
Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
Not available
S-EPMC6639714
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
